Literature DB >> 9143692

Redox regulation of cellular activation.

H Nakamura1, K Nakamura, J Yodoi.   

Abstract

Growing evidence has indicated that cellular reduction/oxidation (redox) status regulates various aspects of cellular function. Oxidative stress can elicit positive responses such as cellular proliferation or activation, as well as negative responses such as growth inhibition or cell death. Cellular redox status is maintained by intracellular redox-regulating molecules, including thioredoxin (TRX). TRX is a small multifunctional protein that has a redox-active disulfide/dithiol within the conserved active site sequence: Cys-Gly-Pro-Cys. Adult T cell leukemia-derived factor (ADF), which we originally defined as an IL-2 receptor alpha-chain/Tac inducer produced by human T cell lymphotrophic virus-I (HTLV-I)-transformed T cells, has been identified as human TRX. TRX/ADF is a stress-inducible protein secreted from cells. TRX/ADF has both intracellular and extracellular functions as one of the key regulators of signaling in the cellular responses against various stresses. Extracellularly, TRX/ADF shows a cytoprotective activity against oxidative stress-induced apoptosis and a growth-promoting effect as an autocrine growth factor. Intracellularly, TRX/ADF is involved in the regulation of protein-protein or protein-nucleic acid interactions through the reduction/oxidation of protein cysteine residues. For example, TRX/ADF translocates from the cytosol into the nucleus by a variety of cellular stresses, to regulate the expression of various genes through the redox factor-1 (Ref-1)/APEX. Further studies to clarify the regulatory roles of TRX/ADF and its target molecules may elucidate the intracellular signaling pathways in the responses against various stresses. The concept of "redox regulation" is emerging as an understanding of the novel mechanisms in the pathogenesis of several disorders, including viral infections, immunodeficiency, malignant transformation, and degenerative disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143692     DOI: 10.1146/annurev.immunol.15.1.351

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  196 in total

1.  Reversible S-glutathionylation of human 6-pyruvoyl tetrahydropterin synthase protects its enzymatic activity.

Authors:  Satoshi Hara; Soichiro Fukumura; Hiroshi Ichinose
Journal:  J Biol Chem       Date:  2018-12-04       Impact factor: 5.157

2.  Attenuation of indomethacin-induced gastric mucosal injury by prophylactic administration of sake yeast-derived thioredoxin.

Authors:  Atsushi Nakajima; Toshiro Fukui; Yu Takahashi; Masanobu Kishimoto; Masao Yamashina; Shinji Nakayama; Yutaku Sakaguchi; Katsunori Yoshida; Kazushige Uchida; Akiyoshi Nishio; Junji Yodoi; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2012-03-09       Impact factor: 7.527

3.  Hepatoprotection via the IL-6/Stat3 pathway.

Authors:  Rebecca Taub
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 4.  Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling.

Authors:  Carl Nathan
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

5.  Biological functions of the disulfides in bovine pancreatic deoxyribonuclease.

Authors:  Wei-Jung Chen; I-Shuan Lee; Ching-Ying Chen; Ta-Hsiu Liao
Journal:  Protein Sci       Date:  2004-04       Impact factor: 6.725

6.  Modulation of acid-sensing ion channels: molecular mechanisms and therapeutic potential.

Authors:  Xiang-Ping Chu; Christopher J Papasian; John Q Wang; Zhi-Gang Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-11-18

7.  Thioredoxin-related protein of 14 kDa is an efficient L-cystine reductase and S-denitrosylase.

Authors:  Irina Pader; Rajib Sengupta; Marcus Cebula; Jianqiang Xu; Jon O Lundberg; Arne Holmgren; Katarina Johansson; Elias S J Arnér
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

8.  Growth promoting effect of thioredoxin on intestinal epithelial cells.

Authors:  Shigeo Takaishi; Mitsutaka Sawada; Hiroshi Seno; Takahisa Kayahara; Yukari Morita-Fujisawa; Hiroaki Fukuzawa; Tsutomu Chiba
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

9.  Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy.

Authors:  Mitsutaka Yamamoto; Guiping Yang; Chull Hong; Jing Liu; Eric Holle; Xianzhong Yu; Thomas Wagner; Stephen F Vatner; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

10.  Rapid Identification of New Biomarkers for the Classification of GM1 Type 2 Gangliosidosis Using an Unbiased 1H NMR-Linked Metabolomics Strategy.

Authors:  Benita C Percival; Yvonne L Latour; Cynthia J Tifft; Martin Grootveld
Journal:  Cells       Date:  2021-03-05       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.